Literature DB >> 21516550

Bulimia nervosa among methamphetamine dependent adults: association with outcomes three years after treatment.

Suzette Glasner-Edwards1, Larissa J Mooney, Patricia Marinelli-Casey, Maureen Hillhouse, Alfonso Ang, Richard Rawson.   

Abstract

Although weight loss is among the most commonly cited reasons for using methamphetamine (MA), little is known about the association between eating disorders and treatment outcomes in this population. This study examined psychiatric, substance use, and functional outcomes of MA users (N = 526) with bulimia nervosa 3 years after treatment for MA dependence. Bulimia nervosa was observed among 2.4% (N = 13) of the participants and was associated with poorer MA use outcomes, increased health service utilization, and higher levels of functional impairment. Addressing MA use among adults with eating disorders may be helpful as a means of improving treatment outcomes.

Entities:  

Mesh:

Year:  2011        PMID: 21516550      PMCID: PMC3159413          DOI: 10.1080/10640266.2011.566149

Source DB:  PubMed          Journal:  Eat Disord        ISSN: 1064-0266            Impact factor:   3.222


  20 in total

1.  Practice guideline for the treatment of patients with eating disorders (revision). American Psychiatric Association Work Group on Eating Disorders.

Authors: 
Journal:  Am J Psychiatry       Date:  2000-01       Impact factor: 18.112

2.  Studying addicts over time: methodology and preliminary findings.

Authors:  D N Nurco; A J Bonito; M Lerner; M B Balter
Journal:  Am J Drug Alcohol Abuse       Date:  1975       Impact factor: 3.829

3.  Substance use among women with eating disorders.

Authors:  M W Wiederman; T Pryor
Journal:  Int J Eat Disord       Date:  1996-09       Impact factor: 4.861

4.  A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence.

Authors:  Richard A Rawson; Patricia Marinelli-Casey; M Douglas Anglin; Alice Dickow; Yvonne Frazier; Cheryl Gallagher; Gantt P Galloway; James Herrell; Alice Huber; Michael J McCann; Jeanne Obert; Susan Pennell; Chris Reiber; Denna Vandersloot; Joan Zweben
Journal:  Addiction       Date:  2004-06       Impact factor: 6.526

5.  Psychiatric symptoms in methamphetamine users.

Authors:  Joan E Zweben; Judith B Cohen; Darrell Christian; Gantt P Galloway; Michelle Salinardi; David Parent; Martin Iguchi
Journal:  Am J Addict       Date:  2004 Mar-Apr

Review 6.  Co-morbidity of eating disorders and substance abuse review of the literature.

Authors:  C C Holderness; J Brooks-Gunn; M P Warren
Journal:  Int J Eat Disord       Date:  1994-07       Impact factor: 4.861

7.  An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index.

Authors:  A T McLellan; L Luborsky; G E Woody; C P O'Brien
Journal:  J Nerv Ment Dis       Date:  1980-01       Impact factor: 2.254

8.  Psychopathology in methamphetamine-dependent adults 3 years after treatment.

Authors:  Suzette Glasner-Edwards; Larissa J Mooney; Patricia Marinelli-Casey; Maureen Hillhouse; Alfonso Ang; Richard A Rawson
Journal:  Drug Alcohol Rev       Date:  2010-01

9.  Self-damaging and addictive behaviour in bulimia nervosa. A catchment area study.

Authors:  J H Lacey
Journal:  Br J Psychiatry       Date:  1993-08       Impact factor: 9.319

10.  Psychiatric comorbidity, continuing care and mutual help as predictors of five-year remission from substance use disorders.

Authors:  Jennifer Boyd Ritsher; John D McKellar; John W Finney; Poorni G Otilingam; Rudolf H Moos
Journal:  J Stud Alcohol       Date:  2002-11
View more
  5 in total

Review 1.  Trace amine-associated receptor 1: A promising target for the treatment of psychostimulant addiction.

Authors:  Li Jing; Jun-Xu Li
Journal:  Eur J Pharmacol       Date:  2015-06-16       Impact factor: 4.432

2.  The FODRAT study (FOod addiction, DRugs, Alcohol and Tobacco): first data on food addiction prevalence among patients with addiction to drugs, tobacco and alcohol.

Authors:  B Tinghino; F Lugoboni; A Amatulli; C Biasin; M Bramani Araldi; D Cantiero; M Cremaschini; G L Galimberti; S Giusti; C Grosina; G E G Mulazzani; U Nizzoli
Journal:  Eat Weight Disord       Date:  2020-02-18       Impact factor: 4.652

3.  Methamphetamine use and disordered eating: a case study of an understudied phenomenon.

Authors:  Christina J Duval; Ane A Balkchyan; Ani Sarkisyan; Eric R Pedersen; Jason M Nagata; Talene Keshishian; Stuart B Murray
Journal:  Eat Weight Disord       Date:  2022-02-24       Impact factor: 3.008

Review 4.  Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: Potential therapeutic impacts.

Authors:  Atul P Daiwile; Subramaniam Jayanthi; Jean Lud Cadet
Journal:  Neurosci Biobehav Rev       Date:  2022-04-20       Impact factor: 9.052

Review 5.  A clinical approach to the assessment and management of co-morbid eating disorders and substance use disorders.

Authors:  Claire Gregorowski; Soraya Seedat; Gerhard P Jordaan
Journal:  BMC Psychiatry       Date:  2013-11-07       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.